These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 8100553)

  • 1. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas.
    Kanavaros P; Jiwa NM; de Bruin PC; van der Valk P; Noorduyn LA; van Heerde P; Gordijn R; Horstman A; Mullink R; Willemze R
    J Pathol; 1992 Nov; 168(3):307-15. PubMed ID: 1335046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis.
    Sandvej KB; Hamilton-Dutoit SJ; Pallesen G
    Leuk Lymphoma; 1993 Jan; 9(1-2):95-101. PubMed ID: 7682882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
    Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
    Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas.
    Herbst H; Dallenbach F; Hummel M; Niedobitek G; Finn T; Young LS; Rowe M; Müller-Lantzsch N; Stein H
    Blood; 1991 Nov; 78(10):2666-73. PubMed ID: 1668608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus.
    Siebert JD; Ambinder RF; Napoli VM; Quintanilla-Martinez L; Banks PM; Gulley ML
    Hum Pathol; 1995 Nov; 26(11):1191-5. PubMed ID: 7590691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease.
    Carbone A; Gloghini A; Zanette I; Canal B; Rizzo A; Volpe R
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(1):39-45. PubMed ID: 7679848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
    Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS
    Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease.
    Khan G; Naase MA
    J Clin Pathol; 1995 Sep; 48(9):845-8. PubMed ID: 7490319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
    Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
    Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.
    Jiwa NM; Kanavaros P; van der Valk P; Walboomers JM; Horstman A; Vos W; Mullink H; Meijer CJ
    J Clin Pathol; 1993 Mar; 46(3):211-7. PubMed ID: 8385158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
    Pinkus GS; Lones M; Shintaku IP; Said JW
    Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large-cell KI-1-positive lymphomas in HIV-1-positive patients.
    Boiocchi M; De Re V; Gloghini A; Vaccher E; Dolcetti R; Marzotto A; Bertola G; Carbone A
    Int J Cancer; 1993 Apr; 54(1):53-9. PubMed ID: 8386709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
    Delsol G; Brousset P; Chittal S; Rigal-Huguet F
    Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.